Investment advice you can actually understand
Results 61 - 70 of 2718 : Previous 3 4 5 6 7 8 9 10 11 Next
These two simple metrics can save you a lot of pain.
This Just In: Upgrades and Downgrades
Why doesn't MKM like Lilly?
Exelixis sells off a preclinical program.
2-Star Stocks Poised to Plunge: Progenics?
Market-lagging returns could be written in this 2-Star.
If You Can't Beat 'Em, Join 'Em: Amgen Goes Generic
Biosimilars are coming -- might as well get a piece of the action.
The biotech is doing something right.
Is Gilead Sciences' Stock a Bargain by the Numbers?
Let's take a look.
Checking the Quality of Gilead's Growth
These two simple metrics can save you a lot of pain.
Momentum Ideas: 10 Golden Cross Stocks With Strong Profitability
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK